Uterine fibroids: current perspectives

References

• RyanGLSyropCHVan VoorhisBJRole, epidemiology, and natural history of benign uterine mass lesionsClin Obstet Gynecol20054831232415805789
   PubMed Web of Science ®Google Scholar
• WallachEEVlahosNFUterine myomas: an overview of development, clinical features, and managementObstet Gynecol200410439340615292018
   PubMed Web of Science ®Google Scholar
• SankaranSManyondaITMedical management of fibroidsBest Pract Res Clin Obstet Gynaecol200822465567618468953
   PubMed Web of Science ®Google Scholar
• ParkerWHEtiology, symptomatology, and diagnosis of uterine myomasFertil Steril200787472573617430732
   PubMed Web of Science ®Google Scholar
• ReinMSBarbieriRLFriedmanAJProgesterone: a critical role in the pathogenesis of uterine myomasAm J Obstet Gynecol19951721 Pt114187847524
   PubMed Web of Science ®Google Scholar
• AndersenJGrowth factors and cytokines in uterine leiomyomasSemin Reprod Endocrinol19961432692828885057
   PubMedGoogle Scholar
• FieldsKRNeinsteinLSUterine myomas in adolescents: case reports and a review of the literatureJ Pediatr Adolesc Gynecol1996941951988957774
   PubMedGoogle Scholar
• CramerSFPatelAThe frequency of uterine leiomyomasAm J Clin Pathol19909444354382220671
   PubMed Web of Science ®Google Scholar
• Day BairdDDunsonDBHillMCCousinsDSchectmanJMHigh cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidenceAm J Obstet Gynecol2003188110010712548202
   PubMed Web of Science ®Google Scholar
• LaughlinSKSchroederJCBairdDDNew directions in the epidemiology of uterine fibroidsSemin Reprod Med201028320421720414843
   PubMed Web of Science ®Google Scholar
• SchwartzSMEpidemiology of uterine leiomyomataClin Obstet Gynecol200144231632611344995
   PubMed Web of Science ®Google Scholar
• PurdieDMGreenACEpidemiology of endometrial cancerBest Pract Res Clin Obstet Gynaecol200115334135411476557
   PubMed Web of Science ®Google Scholar
• ColditzGAEpidemiology of breast cancer. Findings from the nurses’ health studyCancer199371Suppl 4148014898431884
   PubMed Web of Science ®Google Scholar
• BairdDDDunsonDBWhy is parity protective for uterine fibroids?Epidemiology200314224725012606893
   PubMed Web of Science ®Google Scholar
• ParazziniFRisk factors for clinically diagnosed uterine fibroids in women around menopauseMaturitas200655217417916533580
   PubMed Web of Science ®Google Scholar
• WiseLAPalmerJRHarlowBLReproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American women:a prospective studyAm J Epidemiol2004159211312314718211
   PubMed Web of Science ®Google Scholar
• BurbankFChildbirth and myoma treatment by uterine artery occlusion: do they share a common biology?J Am Assoc Gynecol Laparosc200411213815215200765
   PubMedGoogle Scholar
• WiseLAPalmerJRHarlowBLRisk of uterine leiomyomata in relation to tobacco, alcohol and caffeine consumption in the Black Women’s Health StudyHum Reprod20041981746175415218005
   PubMed Web of Science ®Google Scholar
• StewartEANowakRANew concepts in the treatment of uterine leiomyomasObstet Gynecol1998924 Pt 16246279764641
   PubMed Web of Science ®Google Scholar
• LeppertPCCatherinoWHSegarsJHA new hypothesis about the origin of uterine fibroids based on gene expression profiling with microarraysAm J Obstet Gynecol2006195241542016635466
   PubMed Web of Science ®Google Scholar
• CramerSFMannLCalianeseEDaleyJWilliamsonKAssociation of seedling myomas with myometrial hyperplasiaHum Pathol200940221822518799191
   PubMed Web of Science ®Google Scholar
• RogersRNorianJMalikMMechanical homeostasis is altered in uterine leiomyomaAm J Obstet Gynecol2008198447418395046
   PubMed Web of Science ®Google Scholar
• CatherinoWSalamaAPotlog-NahariCLeppertPTsibrisJSegarsJGene expression studies in leiomyomata: new directions for researchSemin Reprod Med2004222839015164303
   PubMed Web of Science ®Google Scholar
• BairdDDKesnerJSDunsonDBLuteinizing hormone in premeno-pausal women may stimulate uterine leiomyomata developmentJ Soc Gynecol Investig2006132130135
   Google Scholar
• WirthMMMeierEAFredricksonBLSchultheissOCRelationship between salivary cortisol and progesterone levels in humansBiol Psychol200774110410716904811
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Clinical ExcellenceUterine Artery Embolisation for FibroidsLondonNICE2010 Available from: http://www.nice.org.uk/nicemedia/live/11025/51706/51706.pdfAccessed on October 21, 2013
   Google Scholar
• SabryMAl-HendyAInnovative oral treatments of uterine leiomyomaObstet Gynecol Int2012201294363510.1155/2012/94363522518167
   PubMedGoogle Scholar
• SchwartzSMMarshallLMBairdDDEpidemiologic contributions to understanding the etiology of uterine leiomyomataEnviron Health Perspect2000108Suppl 582182711035989
   PubMed Web of Science ®Google Scholar
• OkoloSIncidence, aetiology and epidemiology of uterine fibroidsBest Pract Res Clin Obstet Gynaecol200822457158818534913
   PubMed Web of Science ®Google Scholar
• WegienkaGBairdDDHertz-PicciottoISelf-reported heavy bleeding associated with uterine leiomyomataObstet Gynecol2003101343143712636944
   PubMed Web of Science ®Google Scholar
• LippmanSAWarnerMSamuelsSOliveDVercelliniPEskenaziBUterine fibroids and gynecologic pain symptoms in a population-based studyFertil Steril20038061488149414667888
   PubMed Web of Science ®Google Scholar
• ZimmermannABernuitDGerlingerCSchaefersMGeppertKPrevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 womenBMC Womens Health201212622448610
   PubMed Web of Science ®Google Scholar
• SomiglianaEVercelliniPDaguatiRPasinRDe GiorgiOCrosignaniPGFibroids and female reproduction:a critical analysis of the evidenceHum Reprod Update20071346547617584819
   PubMed Web of Science ®Google Scholar
• ParkerWHEtiology, symptomatology, and diagnosis of uterine myomasFertil Steril200787472573617430732
   PubMed Web of Science ®Google Scholar
• LevensEDWesleyRPremkumarABlockerWNiemanLKMagnetic resonance imaging and transvaginal ultrasound for determining fibroid burden: implications for research and clinical careAm J Obstet Genecol20092005537. e1e7
   Web of Science ®Google Scholar
• VolkersNAHehenkampWJSpijkerboerAMMR reproducibility in the assessment of uterine fibroids for patients scheduled for uterine artery embolizationCardiovasc Intervent Radiol20083126026818057985
   PubMed Web of Science ®Google Scholar
• ZawinMMcCarthySScouttLMComiteFHigh-field MRI and US evaluation of the pelvis in women with leiomyomasMagn Reson Imaging199083713762202877
   PubMed Web of Science ®Google Scholar
• DueholmMLundorfEHansenESLedertougSOlesenFEvaluation of the uterine cavity with magnetic resonance imaging, transvaginal sonography, hysterosonographic examination, and diagnostic hysteroscopyFertil Steril20017635035711476785
   PubMed Web of Science ®Google Scholar
• DueholmMLundorfESorensenJSLedertougSOlesenFLaursenHReproducibility of evaluation of the uterus by transvaginal sonography, hysterosonographic examination, hysteroscopy and magnetic resonance imagingHum Reprod20021719520011756387
   PubMed Web of Science ®Google Scholar
• WildeSScott-BarrettSRadiological appearances of uterine fibroidsIndian J Radiol Imaging200919322223119881092
   PubMedGoogle Scholar
• RoyCBierryGEl GhaliSBuyXRossiniAAcute torsion of uterine leiomyoma: CT featuresAbdom Imaging20053012012315647881
   PubMedGoogle Scholar
• DueholmMLundorfEHansenESLedertougSOlesenFAccuracy of magnetic resonance imaging and transvaginal ultrasonography in the diagnosis, mapping, and measurement of uterine myomasAm J Obstet Gynecol200218640941511904599
   PubMed Web of Science ®Google Scholar
• WeinrebJCBarkoffNDMegibowADemopoulosRThe value of MR imaging in distinguishing leiomyomas from other solid pelvic masses when sonography is indeterminateAJR Am J Roentgenol19891542952992105017
   PubMed Web of Science ®Google Scholar
• OmariEAVargheseTKliewerMAA novel saline infusion sonohysterography-based strain imaging approach for evaluation of uterine abnormalities in vivo: preliminary resultsJ Ultrasound Med201231460961522441918
   PubMed Web of Science ®Google Scholar
• DavidsonKGDubinskyTJUltrasonographic evaluation of the endometrium in postmenopausal vaginal bleedingRadiol Clin North Am20034176978012899491
   PubMed Web of Science ®Google Scholar
• CohenJRLuxmanDSagiJYovelIWolmanIDavidMPSonohysterography for distinguishing endometrial thickening from endometrial polyps in postmenopausal bleedingUltrasound Obstet Gynecol1994422723012797187
   PubMed Web of Science ®Google Scholar
• ByunJYKimSEChoiBGDiffuse and focal adenomyosis: MR imaging findingsRadioGraphics199919Suppl 1s161s17010517452
   PubMed Web of Science ®Google Scholar
• AscherSMArnoldLLPattRHAdenomyosis: Prospective comparison of MR imaging and transvaginal sonographyRadiology19941908038068115630
   PubMed Web of Science ®Google Scholar
• DudiakCMTurnerDAPatelSKArchieJTSilverBNorusisMUterine leiomyomas in the infertile patient: preoperative localization with MR imaging versus US and hysterosalpingographyRadiology19881676276633283833
   PubMed Web of Science ®Google Scholar
• RocheOChavanNAquilinaJRockallARadiological appearances of gynaecological emergenciesInsights Imaging20123326527522696088
   PubMedGoogle Scholar
• LivermoreJAAdusumilliSMRI of benign uterine conditionsAppl Radiol2007369818
   Google Scholar
• BrosensJJde SouzaNMBarkerFGUterine junctional zone: function and diseaseLancet19953465585607658784
   PubMed Web of Science ®Google Scholar
• MuraseESiegelmanESOutwaterEKUterine leiomyomas: histopathologic features, MR imaging findings, differential diagnosis, and treatmentRadiographics1999191179119710489175
   PubMed Web of Science ®Google Scholar
• UedaHTogashiKKonishiIUnusual appearances of uterine leiomyomas: MR imaging findings and their histopathologic backgroundsRadiographics199919Suppl 1s131s14510517450
   PubMed Web of Science ®Google Scholar
• KimJCKimSSParkJY“Bridging vascular sign” in the MR diagnosis of exophytic uterine leiomyomaJ Comput Assist Tomogr200024576010667660
   PubMed Web of Science ®Google Scholar
• DohkeMWatanabeYOkumuraAComprehensive MR Imaging of acute gynecologic diseasesRadiographics20002061551156611112810
   PubMed Web of Science ®Google Scholar
• BurnPRMcCallJMChinnRJVashishtASmithJRHealyJCUterine fibroleiomyoma: MR imaging appearance before and after embolization of uterine arteriesRadiology200021472973410715038
   PubMed Web of Science ®Google Scholar
• Simms-StewartDFletcherHCounselling patients with uterine fibroids: a review of the management and complicationsObstet Gynecol Int2012201253936510.1155/2012/53936522272207
   PubMedGoogle Scholar
• PrittsEAOliveDLWhen should uterine fibroids be treated?Curr Obstet Gynecol Rep2012127180
   Google Scholar
• CarlsonKJMillerBAFowlerFJThe Maine Women’s Health Study: I Outcomes of hysterectomyObstet Gynecol1994835568134066
   PubMed Web of Science ®Google Scholar
• LefebvreGVilosGAllaireCThe management of uterine leiomyomasJ Obstet Gynaecol Can20032539612738981
   PubMedGoogle Scholar
• LaughlinSKStewartEAUterine leiomyomas: individualizing the approach to a heterogeneous conditionObstet Gynecol20111172 Pt 139640321252757
   PubMed Web of Science ®Google Scholar
• LakhaniKPMarshMSPurcellWHardimanPUterine artery blood flow parameters in women with dysfunctional uterine bleeding and uterine fibroids: the effects of tranexamic acidUltrasound Obstet Gynecol1998112832859618854
   PubMed Web of Science ®Google Scholar
• SundströmASeamanHKielerHAlfredssonLThe risk of venous thromboembolism associated with the use of tranexamic acid and other drugs used to treat menorrhagia: a case-control study using the General Practice Research DatabaseBJOG2009116919719016686
   PubMed Web of Science ®Google Scholar
• IpPPLamKWCheungCLTranexamic acid-associated necrosis and intralesional thrombosis of uterine leiomyomas: a clinicopathologic study of 147 cases emphasizing the importance of drug-induced necrosis and early infarcts in leiomyomasAm J Surg Pathol2007311215122417667546
   PubMed Web of Science ®Google Scholar
• Abdel-RahmanMYSabryMAl-HendyAMedical Treatment of Fibroid to Decrease Rate of HysterectomyAl-HendyAHysterectomyRejekaInTech2012115128
   Google Scholar
• MarshallLMSpiegelmanDGoldmanMBA prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomataFertil Steril19987034324399757871
   PubMed Web of Science ®Google Scholar
• ChiaffarinoFParazziniFLa VecchiaCMarsicoSSuraceMRicciEUse of oral contraceptives and uterine fibroids: results from a case-control studyBr J Obstet Gynaecol1999106885786010453838
   PubMedGoogle Scholar
• ParazziniFNegriELa VecchiaCFedeleLRabaiottiMLuchiniLOral contraceptive use and risk of uterine fibroidsObstet Gynecol19927934304331738528
   PubMed Web of Science ®Google Scholar
• FriedmanAJDalyMJuneau-NorcrossMGleasonRReinMSLeBoffMLong-term medical therapy for leiomyomata uteri: a prospective, randomized study of leuprolide acetate depot plus either estrogen-progestin or progestin ‘add-back’ for 2 yearsHum Reprod199499161816257836510
   PubMed Web of Science ®Google Scholar
• OrsiniGLaricchiaLFanelliMLow-dose combination oral contraceptives use in women with uterine leiomyomasMinerva Ginecol2002543253261 Italian12063441
   PubMedGoogle Scholar
• VenkatachalamSBagrateeJSMoodleyJMedical management of uterine fibroids with medroxyprogesterone acetate (Depo Provera): a pilot studyJ Obstet Gynaecol200424779880015763792
   PubMedGoogle Scholar
• The management of menorrhagia in secondary careEvidence-based clinical guideline No. 5LondonRoyal College of Obstetricians and Gynaecologists1999
   Google Scholar
• IrvineGACampbell-BrownMBLumsdenMARandomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagiaBr J Obstet Gynaecol19981055925989647148
   PubMedGoogle Scholar
• MaruoTLaoag-FernandezJBPakarinenPEffects of the levonorgestrel-releasing intrauterine system on proliferation and apoptosis in the endometriumHum Reprod2001162103210811574499
   PubMed Web of Science ®Google Scholar
• MaruoTOharaNMatsuoHEffects of levonorgestrel-releasing IUS and progesterone receptor modulator PRM CDB-2914 on uterine leiomyomasContraception200775S99S10317531625
   PubMed Web of Science ®Google Scholar
• National Collaborating Centre for Women’s and Children’s HealthHeavy menstrual bleeding: clinical guidelineLondonNational Institute for Clinical Excellence2007
   Google Scholar
• BozziniNRodriguesCJPettiDAEffects of treatment with gonadotropin releasing hormone agonist on the uterine leiomyomata structureActa Obstet Gynecol Scand20038233033412716317
   PubMed Web of Science ®Google Scholar
• CheginiNKornbergLGonadotropin releasing hormone analogue therapy alters signal transduction pathways involving mitogen-activated protein and focal adhesion kinases in leiomyomaJ Soc Gynecol Investig2003102126
   PubMedGoogle Scholar
• CheginiNMaCTangXMEffects of GnRH analogues, ‘add-back’ steroid therapy, antiestrogen and antiprogestins on leiomyoma and myometrial smooth muscle cell growth and transforming growth factor-beta expressionMol Hum Reprod2002121071107812468639
   PubMed Web of Science ®Google Scholar
• CheginiNVeralaJLuoXGene expression profile of leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapyJ Soc Gynecol Investig200310161171
   Google Scholar
• DeligdischLHirschmannSAltchekSPathologic changes in gonadotropin releasing hormone agonist analogue treated uterine leiomyomataFertil Steril1997678378419130887
   PubMed Web of Science ®Google Scholar
• ReinschRCMurphyAAMoralesAJThe effects of RU 486 and leuprolide acetate on uterine artery blood flow in the fibroid uterus: a prospective, randomized studyAm J Obstet Gynecol1994170162316288203418
   PubMed Web of Science ®Google Scholar
• MesiaAFGahrDWildMImmunohistochemistry of vascular changes in leuprolide acetate treated leiomyomasAm J Obstet Gynecol1997176102610299166163
   PubMed Web of Science ®Google Scholar
• RutgersJLSpongCYSinowRLeuprolide acetate treatment and myoma arterial sizeObstet Gynecol1995863863887651647
   PubMed Web of Science ®Google Scholar
• LethabyAVollenhovenBSowterMPre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroidsCochrane Database Syst Rev20002CD00054710796723
   PubMedGoogle Scholar
• MitlakBHCohenFJIn search of optimal long-term female hormone replacement: the potential of selective estrogen receptor modulatorsHorm Res19974841551639378461
   PubMedGoogle Scholar
• PalombaSSammartinoADi CarloCAffinitoPZulloFNappiCEffects of raloxifene treatment on uterine leiomyomas in postmenopausal womenFertil Steril2001761384311438317
   PubMed Web of Science ®Google Scholar
• PalombaSOrioFJrRussoTAntiproliferative and proapoptotic effects of raloxifene on uterine leiomyomas in postmenopausal womenFertil Steril200584115416116009171
   PubMed Web of Science ®Google Scholar
• PremkumarAVenzonDJAvilaNGynecologic and hormonal effects of raloxifene in premenopausal womenFertil Steril20078861637164417662283
   PubMed Web of Science ®Google Scholar
• GiangrandePHMcDonnellDPThe A and B isoforms of the human progesterone receptor: two functionally different transcription factors encoded by a single geneRecent Prog Horm Res19995429131310548881
   PubMedGoogle Scholar
• SpitzIMClinical utility of progesterone receptor modulators and their effect on the endometriumCurr Opin Obstet Gynecol20092131832419602929
   PubMed Web of Science ®Google Scholar
• MaruoTMatsuoHSamotoTEffects of progesterone on uterine leiomyoma growth and apoptosisSteroids20006558559211108863
   PubMed Web of Science ®Google Scholar
• TalaulikarVSManyondaIProgesterone and progesterone receptor modulators in the management of symptomatic uterine fibroidsEur J Obstet Gynecol Reprod Biol201216513514022901974
   PubMed Web of Science ®Google Scholar
• De LeoVMorganteGLa MarcaAA benefit-risk assessment of medical treatment for uterine leiomyomasDrug Safety20022575977912222988
   PubMed Web of Science ®Google Scholar
• EisingerSHMeldrumSFiscellaKle RouxHDGuzickDSLow-dose mifepristone for uterine leiomyomataObstetr Gynecol2003101243250
   PubMed Web of Science ®Google Scholar
• Carbonell EsteveJLAcostaRHerediaBPérezYCastañedaMCHernándezAVMifepristone for the treatment of uterine leiomyomas: a randomized controlled trialObstet Gynecol20081121029103618978102
   PubMed Web of Science ®Google Scholar
• DonnezJTatarchukTFBouchardPPEARL I Study GroupUlipristal acetate versus placebo for fibroid treatment before surgeryN Engl J Med201236640942022296075
   PubMed Web of Science ®Google Scholar
• DonnezJTomaszewskiJVázquezFPEARL II Study GroupUlipristal acetate versus leuprolide acetate for uterine fibroidsN Engl J Med201236642143222296076
   PubMed Web of Science ®Google Scholar
• FiscellaKEisingerSCDB-2914 for uterine leiomyomata treatment: a randomized controlled trialObstet Gynecol20081123707 author reply 707–70818757682
   PubMed Web of Science ®Google Scholar
• SmithIEDowsettMAromatase inhibitors in breast cancerN Engl J Med2003348242431244212802030
   PubMed Web of Science ®Google Scholar
• IshikawaHReierstadSDemuraMHigh aromatase expression in uterine leiomyoma tissues of African-American womenJ Clin Endocrinol Metab20099451752175619240151
   PubMed Web of Science ®Google Scholar
• WilliamsARCritchleyHOOseiJThe effects of the selective progesterone receptor modulator asoprisnil on the morphology of uterine tissues after 3 months treatment in patients with symptomatic uterine leiomyomataHum Reprod20072261696170417339234
   PubMed Web of Science ®Google Scholar
• BedaiwyMALuiJLong-term management of endometriosis: medical therapy and treatment of infertilitySex Reprod Menopause2010835
   Google Scholar
• BairdDTBrownAChengLMifepristone: a novel estrogen-free daily contraceptive pillSteroids20036810–131099110514668004
   PubMed Web of Science ®Google Scholar
• VarelasFKPapanicolaouANVavatsi-ChristakiNMakedosGAVlassisGDThe effect of anastrazole on symptomatic uterine leiomyomataObstet Gynecol2007110364364917766612
   PubMed Web of Science ®Google Scholar
• American University of Beirut Medical CenterAromatase inhibitors for treatment of uterine leiomyomas Available from: http://clinicaltrials.gov/show/NCT00945360 NLM identifier: NCT00945360Accessed September 7, 2010
   Google Scholar
• HöppenerJWMosselmanSRohollPJExpression of insulin-like growth factor-I and -II genes in human smooth muscle tumorsEMBO J198875137913853409868
   PubMed Web of Science ®Google Scholar
• GloudemansTPrinsenIVan UnnikJALipsCJDen OtterWSus-senbachJSInsulin-like growth factor gene expression in human smooth muscle tumorsCancer Res19905020668966952208134
   PubMed Web of Science ®Google Scholar
• NorstedtGLevinovitzAErikssonHRegulation of uterine insulin-like growth factor I mRNA and insulin-like growth factor II mRNA by estrogen in the ratActa Endocrinol (Copenh)198912044664722718698
   PubMedGoogle Scholar
• ReinMSFriedmanAJPandianMRHeffnerLJThe secretion of insulin-like growth factors I and II by explant cultures of fibroids and myometrium from women treated with a gonadotropin-releasing hormone agonistObstet Gynecol1990763 Pt 13883942116610
   PubMed Web of Science ®Google Scholar
• BoehmKDDaimonMGorodeskiIGSheeanLAUtianWHIlanJExpression of the insulin-like and platelet-derived growth factor genes in human uterine tissuesMol Reprod Dev1990272931011979007
   PubMed Web of Science ®Google Scholar
• CohenOSchindelBHomburgRUterine leiomyomata – a feature of acromegalyHum Reprod1998137194519469740454
   PubMed Web of Science ®Google Scholar
• NilssonCGLuukkainenTDiazJAllonenHIntrauterine contraception with levonorgestrel: a comparative randomised clinical performance studyLancet198118220 Pt 15775806110819
   PubMed Web of Science ®Google Scholar
• De LeoVla MarcaAMorganteGSeveriFMPetragliaFAdministration of somatostatin analogue reduces uterine and myoma volume in women with uterine leiomyomataFertil Steril200175363263311239556
   PubMed Web of Science ®Google Scholar
• FeeldersRAHoflandLJvan AkenMOMedical therapy of acromegaly: efficacy and safety of somatostatin analoguesDrugs200969162207222619852525
   PubMed Web of Science ®Google Scholar
• DaviesPHStewartSELancranjanLSheppardMCStewartPMLong-term therapy with long-acting octreotide (Sandostatin-LAR®) for the management of acromegalyClin Endocrinol (Oxf)19984833113169578821
   PubMed Web of Science ®Google Scholar
• MelliMSFarzadiLMadarekEOComparison of the effect of gonadotropin releasing hormone analog (Diphereline) and Cabergoline (Dostinex) treatment on uterine myoma regressionSaudi Med J200728344545017334477
   PubMed Web of Science ®Google Scholar
• Sayyah-MelliMTehrani-GadimSDastranj-TabriziAComparison of the effect of gonadotropin-releasing hormone agonist and dopamine receptor agonist on uterine myoma growth. Histologic, sonographic, and intra-operative changesSaudi Med J20093081024103319668882
   PubMed Web of Science ®Google Scholar
• La MarcaAGiuliniSVitoGOrvietoRVolpeAJasonniVMGestrinone in the treatment of uterine leiomyomata: effects on uterine blood supplyFertil Steril20048261694169615589885
   PubMed Web of Science ®Google Scholar
• CoutinhoEMTreatment of large fibroids with high doses of gestrinoneGynecol Obstet Invest199030144472227612
   PubMed Web of Science ®Google Scholar
• SharanCHalderSKThotaCJaleelTNairSAl-HendyAVitamin D inhibits proliferation of human uterine leiomyoma cells via catechol-O-methyltransferaseFertil Steril201195124725320736132
   PubMed Web of Science ®Google Scholar
• HalderSKGoodwinJSAl-HendyA1,25-Dihydroxyvitamin D3 reduces TGF-beta3-induced fibrosis-related gene expression in human uterine leiomyoma cellsJ Clin Endocrinol Metab2011964E754E76221289245
   PubMed Web of Science ®Google Scholar
• HalderSKGoodwinSAl-HendyAVitamin D exhibits antiestrogenic effects in human uterine leiomyoma cellsFertil Steril2010944S219S220
   Web of Science ®Google Scholar
• HalderSKSharanCGoodwinSAl-HendyA1, 25 dihydroxyvitamin D3 disorganizes actin fibers in human immortalized uterine leiomyoma cellsFertil Steril2009923S127S128
   Google Scholar
• KhanNMukhtarHTea polyphenols for health promotionLife Sci200781751953317655876
   PubMed Web of Science ®Google Scholar
• ChungJEKurisawaMKimYJUyamaHKobayashiSAmplification of antioxidant activity of catechin by polycondensation with acetaldehydeBiomacromolecules20045111311814715016
   PubMed Web of Science ®Google Scholar
• KhanNAfaqFSaleemMAhmadNMukhtarHTargeting multiple signaling pathways by green tea polyphenol (−)-epigallocatechin-3-gallateCancer Res20066652500250516510563
   PubMed Web of Science ®Google Scholar
• ZhangDAl-HendyMRichard-DavisGMontgomery-RiceVRajaratnamVAl-HendyAAntiproliferative and proapoptotic effects of epigallocatechin gallate on human leiomyoma cellsFertil Steril20109451887189319819432
   PubMed Web of Science ®Google Scholar
• van der KooijSMAnkumWMHehenkampWJReview of nonsurgical/minimally invasive treatments for uterine fibroidsCurr Opin Obstet Gynecol201224636837523014141
   PubMed Web of Science ®Google Scholar
• SpiesJBSacksDCredentials for uterine artery embolizationJ Vasc Interv Radiol20041511111314963175
   PubMed Web of Science ®Google Scholar
• GreenwoodCGlickmanMSchwartzPMorseSSDennyDFObstetric and non-malignant gynecologic bleeding: treatment with angiographic embolization radiologyRadiology198716411551593495816
   PubMed Web of Science ®Google Scholar
• GoodwinSVendanthamSMcLucasBFornoAPerellaRPreliminary experience with uterine fibroid embolization for uterine fibroidsJ Vasc Interv Radiol199785175269232565
   PubMed Web of Science ®Google Scholar
• RavinaJHBouretJMCiraru-VigneronNRecourse to particular arterial embolization in the treatment of some uterine leiomyomaBull Acad Natl Med19971812233243 French9235224
   PubMed Web of Science ®Google Scholar
• RavinaJHHerbreteauDCiraru-VigneronNArterial embolisation to treat uterine myomataLancet19953466716727544859
   PubMed Web of Science ®Google Scholar
• HutchinsFLJrWorthington-KirschRBerkowitzRPSelective uterine artery embolization as primary treatment for symptomatic leiomyomata uteriJ Am Assoc Gynecol Laparosc1999627928410459027
   PubMedGoogle Scholar
• SpiesJBScialliARJhaRCInitial results from uterine fibroid embolization for symptomatic leiomyomataJ Vasc Interv Radiol1999101149115710527190
   PubMed Web of Science ®Google Scholar
• PelageJPLe DrefOSoyerPFibroid-related menorrhagia: treatment with superselective embolization of the uterine arteries and midterm follow-upRadiology200021542843110796920
   PubMed Web of Science ®Google Scholar
• WalkerWJPelageJPUterine artery embolisation for symptomatic fibroids: clinical results in 400 women with imaging follow-upBr J Obstet Gynecol200210912631272
   Google Scholar
• PronGBennettJCommonAWallJAschMSnidermanKThe Ontario Uterine Fibroid Embolization Trial. Part 2. Uterine fibroid reduction and symptom relief after uterine artery embolization for fibroidsFertil Steril20037912012712524074
   PubMed Web of Science ®Google Scholar
• SpiesJBAllisonSFlickPPolyvinyl alcohol particles and tris-acryl gelatin microspheres for uterine artery embolization for leiomyomas: results of a randomized comparative studyJ Vasc Interv Radiol20041579380015297582
   PubMed Web of Science ®Google Scholar
• AitkenEKhaundAHamidSAMillanDCampbellSThe normal human myometrium has a vascular spatial gradient absent in small fibroidsHum Reprod2006212669267816807279
   PubMed Web of Science ®Google Scholar
• BanuNSGazeDCBruceHCollinsonPOBelliAMManyondaITMarkers of muscle ischemia, necrosis, and inflammation following uterine artery embolization in the treatment of symptomatic uterine fibroidsAm J Obstet Gynecol2007196213. e1e517346524
   PubMed Web of Science ®Google Scholar
• AndrewsRTBrownPHUterine artery embolization: factors influencing patient radiation exposureRadiology200021771372211110933
   PubMed Web of Science ®Google Scholar
• NikolicBAbbaraSLevyEInfluence of radiographic technique and equipment on adsorbed ovarian dose associated with uterine artery embolizationJ Vasc Interv Radiol2000111173117811041474
   PubMed Web of Science ®Google Scholar
• ZupiEPocekMDauriMSelective uterine artery embolization in the management of uterine myomasFertil Steril20037910711112524072
   PubMed Web of Science ®Google Scholar
• WhiteAMBanovacFSpiesJBPatient radiation exposure during uterine fibroid embolization and the dose attributable to aortographyJ Vasc Interv Radiol20071857357617446550
   PubMed Web of Science ®Google Scholar
• Worthington-KirschRKollerNETime course of pain after uterine artery embolization for fibroid diseaseMedscape Womens Health200272412142860
   PubMedGoogle Scholar
• SpiesJBAscherSARothARKimJLevyEBGomez-JorgeJUterine artery embolization for leiomyomataObstet Gynecol200198293411430952
   PubMed Web of Science ®Google Scholar
• PronGMocarskiEBennetJTolerance, hospital stay, and recovery after uterine artery embolization for fibroids: the Ontario Uterine Fibroid Embolization TrialJ Vasc Interv Radiol2003141243125014551270
   PubMed Web of Science ®Google Scholar
• BrunoJSterbisKFlickPRecovery after uterine artery embolization for leiomyomas: a detailed analysis of its duration and severityJ Vasc Interv Radiol20041580180715297583
   PubMed Web of Science ®Google Scholar
• Worthington-KirschRSpiesJBMyersERThe Fibroid Registry for Outcomes Data (FIBROID) for uterine embolization: short term outcomesObstet Gynecol2005106525915994617
   PubMed Web of Science ®Google Scholar
• TropeanoGAmorosoSScambiaGNon-surgical management of uterine fibroidsHum Reprod Update200814325927418344356
   PubMed Web of Science ®Google Scholar
• LumsdenMAModern management of fibroidsObstet Gynaecol Reprod Med20102038286
   Google Scholar
• GuptaJKSinhaALumsdenMHickeyMUterine artery embolization for symptomatic uterine fibroidsCochrane Database Syst Rev20125CD00507322592701
   PubMed Web of Science ®Google Scholar
• MaraMFucikovaaZMaskovaJKuzelaJHaakovaLUterine fibroid embolization versus myomectomy in women wishing to preserve fertility: preliminary results of a randomized controlled trialEur J Obstet Gynecol Reprod Biol200612622623316293363
   PubMed Web of Science ®Google Scholar
• MaraMMaskovaJFucikovaZKuzelDBelsanTSosnaOMidterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomyCardiovasc InterventRadiol2008317385
   PubMed Web of Science ®Google Scholar
• MossJGCooperKGKhaundARandomised comparison of uterine artery embolization (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5-year resultsBJOG201111893694421481151
   PubMed Web of Science ®Google Scholar
• van der KooijSMHehenkampWJVolkersNAUterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5-year outcome from the randomized EMMY trialAm J Obstet Gynecol2010203105. e1e1320579960
   PubMed Web of Science ®Google Scholar
• HomerHSaridoganEUterine artery embolization for fibroids is associated with an increased risk of miscarriageFertil Steril20109432433019361799
   PubMed Web of Science ®Google Scholar
• StewartEAGedroycWMTempanyCMFocused ultrasound treatment of uterine fibroid tumors:safety and feasibility of a noninvasive thermoablative techniqueAm J Obstet Gynecol2003189485412861137
   PubMed Web of Science ®Google Scholar
• TempanyCMStewartEAMcDannoldNQuadeBJJoleszFAHynynenKMR imaging-guided focused ultrasound surgery of uterine leiomyomas: a feasibility studyRadiology200322689790512616023
   PubMed Web of Science ®Google Scholar
• HindleyJGedroycWMReganLMRI guidance of focused ultrasound therapy of uterine fibroids: early resultsAJR Am J Roentgenol20041831713171915547216
   PubMed Web of Science ®Google Scholar
• StewartEARabinoviciJTempanyCMClinical outcomes of focused ultrasound surgery for the treatment of uterine fibroidsFertil Steril200685222916412721
   PubMed Web of Science ®Google Scholar
• VoogtMJTrillaudHKimYSVolumetric feedback ablation of uterine fibroids using magnetic resonance-guided high intensity focused ultrasound therapyEur Radiol20122241141721901565
   PubMed Web of Science ®Google Scholar
• RabinoviciJDavidMFukunishiHPregnancy outcome after magnetic resonance-guided focused ultrasound surgery (MRgFUS) for conservative treatment of uterine fibroidsFertil Steril20109319920919013566
   PubMed Web of Science ®Google Scholar
• MaconochieNDoylePPriorSSimmonsRRisk factors for first trimester miscarriage; results from a UK-population-based case– control studyBJOG200711417018617305901
   PubMed Web of Science ®Google Scholar
• Garza-LealJGToubDHernández LeónITranscervical, intrauterine ultrasound-guided radiofrequency ablation of uterine fibroids with the VizAblate System: safety, tolerability, and ablation results in a closed abdomen settingGynecol Surg201183327334
   Google Scholar
• LeeBBRadiofrequency ablation of uterine leiomyomata: a new minimally invasive hysterectomy alternativeObstet Gynecol20029949S
   Google Scholar
• ChudnoffSGBermanJMLevineDJHarrisMGuidoRSBanksEOutpatient procedure for the treatment and relief of symptomatic uterine myomasObstet Gynecol201312151075108223635746
   PubMed Web of Science ®Google Scholar
• SchirmerBDIntra-operative and laparoscopic ultrasoundHolzheimerRGMannickJASurgical Treatment: Evidence-based and Problem-orientedMunichZuckschwerdt2001
   Google Scholar
• LethabyAVollenhovenBSowterMCPre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroidsCochrane Database Syst Rev20012CD00054711405968
   PubMedGoogle Scholar
• VesseyMPVillard-MackintoshLMcPhersonKCoulterAYeatesDThe epidemiology of hysterectomy: findings in a large cohort studyBr J Obstet Gynaecol1992994024401622913
   PubMedGoogle Scholar
• Malek-MellouliMBen AmaraFYoussefAHysteroscopic myomectomyTunis Med20129045846222693086
   PubMedGoogle Scholar
• MavrelosDBen-NagiJDaviesAThe value of preoperative treatment with GnRH analogues in women with submucous fibroids: a double-blind, placebo-controlled randomized trialHum Reprod2010252264226920663795
   PubMed Web of Science ®Google Scholar
• GambadauroPGudmundssonJTorrejónRIntrauterine adhesions following conservative treatment of uterine fibroidsObstet Gynecol Int2012201285326922190959
   PubMedGoogle Scholar
• PrittsEAParkerWHOliveDLFibroids and infertility: an updated systematic review of the evidenceFertil Steril2009911215122318339376
   PubMed Web of Science ®Google Scholar
• TinelliAHurstBSHudelistGLaparoscopic myomectomy focusing on the myoma pseudocapsule: technical and outcome reportsHum Reprod20122742743522095838
   PubMed Web of Science ®Google Scholar
• DesaiPPatelPFibroids, infertility and laparoscopic myomectomyJ Gynecol Endosc Surg20112364222442534
   PubMedGoogle Scholar
• KongnyuyEJWiysongeCSInterventions to reduce haemorrhage during myomectomy for fibroidsCochrane Database Syst Rev2011CD00535522071823
   PubMed Web of Science ®Google Scholar
• SawinSWPilevskyNDBerlinJAComparability of perioperative morbidity between abdominal myomectomy and hysterectomy for women with uterine leiomyomasAm J Obstet Gynecol200018361448145511120509
   PubMed Web of Science ®Google Scholar
• MachupalliSNorkusEPMukherjeeTKReillyKDAbdominal Myo-mectomy Increases Fertility OutcomeGynecol Obstet20133144
   Google Scholar
• SalamaSSKılıçGSUterine fibroids and current clinical challengesJ Turkish-German Gynecol Assoc2013144045
   Google Scholar
• TaranFABrownHLStewartEARacial diversity in uterine leiomyoma clinical studiesFertil Steril2010941500150319969296
   PubMed Web of Science ®Google Scholar
• hysterectomy-association.org.uk [homepage on the Internet]Latest hysterectomy statistics in UK for the year 2011 to 20122013 [updated January 2, 2013; cited June 24, 2013]. Available from: http://www.hysterectomy-association.org.uk/index.php/research/latest-hysterectomy-statistics-in-uk-for-the-year-2011-to-2012/Accessed June 24, 2013
   Google Scholar
• OkoloSIncidence, aetiology and epidemiology of uterine fibroidsBest Pract Res Clin Obstet Gynaecol20082257158818534913
   PubMed Web of Science ®Google Scholar
• NICE Clinical GuidelineHeavy Menstrual Bleeding National Collaborating Centre for Women’s and Children’s HealthLondonRCOG Press2007
   Google Scholar
• Royal College of Obstetricians and GynaecologistsConsent Advice 4: Abdominal Hysterectomy for Benign ConditionsLondonRCOG Press2009
   Google Scholar
• HarlowBLWeissNSLoftonSThe epidemiology of sarcomas of the uterusJ Natl Cancer Inst1986763994023456457
   PubMed Web of Science ®Google Scholar
• EchtGJepsonJSteelJTreatment of uterine sarcomasCancer19906635392354406
   PubMed Web of Science ®Google Scholar
• RosePGPiverMSTsukadaYLauTPatterns of metastasis in uterine sarcoma. An autopsy studyCancer1989639359382914299
   PubMed Web of Science ®Google Scholar
• UedaSMKappDSCheungMKTrends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deathsAm J Obstet Gynecol2008198218. e1e618226630
   PubMed Web of Science ®Google Scholar
• ZivanovicOLeitaoMMIasonosAStage-specific outcomes of patients with uterine leiomyosarcoma:a comparison of the International Federation of Gynecology and Obstetrics and American Joint Committee on Cancer staging systemsJ Clin Oncol2009272066207219255317
   PubMed Web of Science ®Google Scholar
• LeitaoMMSonodaYBrennanMFBarakatRRChiDSIncidence of lymph node and ovarian metastases in leiomyosarcoma of the uterusGynecol Oncol20039120921214529683
   PubMed Web of Science ®Google Scholar
• YannopoulosKStoutAPSmooth muscle tumors in childrenCancer19621595814008985
   PubMed Web of Science ®Google Scholar
• WeissSWGoldblumJRLeiomyosarcomaEnzinger and Weiss’s Soft Tissue Tumors4th edPhiladelphiaMosby-Harcourt2001p727p748
   Google Scholar
• de SaintAubainSomerhausenNFletcherCDLeiomyosarcoma of soft tissue in children: clinicopathologic analysis of 20 casesAm J Surg Pathol237755763
   Web of Science ®Google Scholar
• D’AngeloEPratJUterine sarcomas :a reviewGynecol Oncol2010116113113919853898
   PubMed Web of Science ®Google Scholar
• PerriTKorachJSadetzkiSObermanBFridmanEBen-BaruchGUterine leiomyosarcoma: does the primary surgical procedure matterInt J Gynecol Cancer20091925726019396005
   PubMed Web of Science ®Google Scholar
• van MeursHSDielesJJStelHVA uterine leiomyoma in which a leiomyosarcoma with osteoclast-like giant cells and a metastasis of a ductal breast carcinoma are presentAnn Diagn Pathol2012161677021216642
   PubMed Web of Science ®Google Scholar
• GiuntoliII RLMetzingerDSDiMarcoCSRetrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapyGynecol Oncol20038946046912798712
   PubMed Web of Science ®Google Scholar
• KappDSShinJYChanJKPrognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomyCancer200811282083018189292
   PubMed Web of Science ®Google Scholar
• HensleyMLBlessingJAMannelRRosePGFixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trialGynecol Oncol200810932933418534250
   PubMed Web of Science ®Google Scholar
• HensleyMLIshillNSoslowRAdjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: results of a prospective studyGynecol Oncol200911256356719135708
   PubMed Web of Science ®Google Scholar
• HardmanMPRomanJJBurnettAFSantinADMetastatic uterine leiomyosarcoma regression using an aromatase inhibitorObstet Gynecol200711051852017666649
   PubMed Web of Science ®Google Scholar